Intellia Therapeutics
NTLA
NTLA
294 hedge funds and large institutions have $720M invested in Intellia Therapeutics in 2025 Q1 according to their latest regulatory filings, with 51 funds opening new positions, 95 increasing their positions, 96 reducing their positions, and 45 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1% less repeat investments, than reductions
Existing positions increased: 95 | Existing positions reduced: 96
38% less capital invested
Capital invested by funds: $1.16B → $720M (-$438M)
Holders
294
Holding in Top 10
2
Calls
$7.04M
Puts
$6.43M
Top Buyers
| 1 | +$38.2M | |
| 2 | +$10.2M | |
| 3 | +$5.68M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$4.79M |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
+$3.96M |
Top Sellers
| 1 | -$8.16M | |
| 2 | -$7.99M | |
| 3 | -$7.02M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.21M |
| 5 |
VPC
Vestal Point Capital
New York
|
-$6.12M |